Low Disease Thresholds up to Three Years in Ixekizumab-Treated Patients with Psoriatic Arthritis in SPIRIT-P1 and SPIRIT-P2

Kavanaugh, A, Helliwell, P orcid.org/0000-0002-4155-9105, Sesin, C et al. (6 more authors) (2021) Low Disease Thresholds up to Three Years in Ixekizumab-Treated Patients with Psoriatic Arthritis in SPIRIT-P1 and SPIRIT-P2. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Metadata

Authors/Creators:
Dates:
  • Published: 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Oct 2021 12:39
Last Modified: 14 Oct 2021 12:39
Status: Published
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)